Perioperative Treatment With Tranexamic Acid in Melanoma
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Melanoma
In brief
Surgery is a key element in the treatment of melanoma, and naturally linked with an inflammatory response and recruitment of innate immune cells. Although surgery has a favorable intent, surgery-induced inflammation, neutrophils in particular, may accelerate growth of local and systemic micrometastases. Thus, improving cancer surgery and modulating the wound microenvironment in ways that benefit the patients is crucial. Repurposing already approved drugs in a cancer setting has gained increasing interest in recent years. Interestingly, tranexamic acid was recently suggested as an anti-cancer drug, capable of reducing tumor growth in experimental animal models and reducing the viability of different melanoma cell lines. As a novel approach, sponsor and investigators will conduct a Randomised Clinical Trial, using perioperative treatment with Tranexamic Acid, aiming to prevent the early relapses for patients with melanoma.
Key facts
- Study ID
- NCT05899465
- Run by
- University of Aarhus
- People needed
- 1204
- Starts
- 2023-08-25
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2025-03-18
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients
- Diagnosed with invasive cutaneous melanoma (pathological stage/tumor grade ≥T2b), defined as either: Breslow thickness >1.0-2.0 mm with presence of ulceration or Breslow thickness >2.0 mm regardless of ulceration status.
- Eligible for surgery (wide local excision and sentinel lymph node biopsy).
- >/=18 years of age and </=80 years of age
- Signed Informed Consent Form
You may not qualify if…
- Patients
- With a prior history of invasive melanoma
- Thromboembolic events within the last 3 months
- Pregnancy
- Active breastfeeding
- Known allergy or hypersensitivity to TXA
- Known and treated epilepsia or previous seizures
- eGFR 0-50
- Current use of tranexamic acid
Where it is running
- Aarhus University Hospital. Dept. of Plastic- and Breast Surgery — Aarhus, Central Jutland, Denmark (enrolling)
- Aalborg University Hospital. Dept. of Plastic- and Breast Surgery. — Aalborg, North Denmark, Denmark (enrolling)
- Copgenhagen University Hospital, Rigshospitalet. Dept. of Plastic Surgery and Burns Treatment — Copenhagen, Denmark (enrolling)
- Copenhagen University Hospital, Herlev. Dept. of Plastic Surgery — Herlev, Denmark
- Sygehus Lillebælt, Vejle Hospital. Dept. of Plastic Surgery — Vejle, Denmark
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.